Navigation Links
Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance
Date:2/26/2008

Genmab Announced Today the Purchase Agreement Entered Into Between Genmab and PDL BioPharma Under Which Genmab Would Acquire PDL's Manufacturing

Facility has Received Antitrust Clearance

COPENHAGEN, February 26 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today that the purchase agreement entered into between Genmab and PDL BioPharma, Inc. under which Genmab would acquire PDL's antibody manufacturing facility has received antitrust clearance from the US antitrust authorities under the Hart-Scott-Rodino Act. This transaction was announced February 21, 2008 and is expected to close by the end of the first quarter of 2008. The US antitrust clearance received today satisfies one of the customary closing conditions required to complete this transaction, which will become effective as soon as all of these conditions have been satisfied.

About Genmab A/S Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or perfo
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
5. Signalife Continues to Procure Purchase Orders, Revenues
6. Pharmaxis Announces Placement of $50 Million and Share Purchase Plan
7. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
8. Orchid Cellmark to Purchase ReliaGene Technologies, Inc.
9. Techne Corporation Announces Share Repurchase Authorization
10. Pharmaxis Closes Share Purchase Plan
11. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...wswire/ -- Prairie Heart Institute of Illinois (PH...rded two statuettes at the first-ever CLIO Healthc...CLIO Healthcare Awards recognizes creative excelle...ndustry and is an extension of the CLIO Awards, on...ns for advertising, design and interactive. PHII w...
(Date:12/1/2009)...-FirstCall/ -- Palatin Technologies, Inc. (NYSE Am...d Trademark Office has issued U.S. Patent No. 7,62...ts." The claims in the issued patent cover a fami...ptide receptor A (NPRA), including PL-3994, Palati...natriuretic compounds, including PL-3994, address ...
(Date:12/1/2009)...-FirstCall/ -- Medizone International, Inc. (OTC B... involving its proprietary AsepticSure(TM) technol... barriers, this time with two very different spore...llis subtilis. These results clearly establish Ase...hnology. "The implications of a 6.7 log reduction ...
(Date:12/1/2009)... organizations will collaborate in comprehensive t...nologies. Their shared efforts will begin in 2010 ... Dallas, TX (PRWEB) December ... of Understanding, Mercy Ships and MediSend Intern...lop sustainable infrastructure in hospitals in dev...
Breaking Biology Technology:Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 2Mercy Ships and MediSend International Partner to Deliver Hope and Healing 3
...eMed, Inc.,(Nasdaq: ENMD ) a clinical-stage pharm...treatment of cancer and inflammatory diseases, tod...ief Executive Officer, will,present a Corporate ov...tech Industry Conference, to be held at the Millen... 2008. Mr. Burns, presentation is scheduled for,Th...
... Senesco,Technologies, Inc. (the "Company") (Amex:...the American Stock Exchange ("AMEX") stating that ...iciencies referenced in the AMEX,s,letters dated J...is based,upon a review of publicly available infor...urities and Exchange Commission filings., Senesco...
...false and misleading information, SOUTH SAN FRANC...xGen,Inc. (OTC Bulletin Board: VXGN.OB), (Logo...XGENLOGO ), Dear Stockholders, On March 19th, Me...VaxGen, issued a press release entitled "MedCap Ur... biotechnologies". We believe this release, one of...
Other Biology Technology:EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference 2Senesco Technologies Regains Compliance With Amex's Continued Listing Requirements 2Senesco Technologies Regains Compliance With Amex's Continued Listing Requirements 3VaxGen Issues Rebuttal to MedCap Letter 2VaxGen Issues Rebuttal to MedCap Letter 3VaxGen Issues Rebuttal to MedCap Letter 4VaxGen Issues Rebuttal to MedCap Letter 5VaxGen Issues Rebuttal to MedCap Letter 6VaxGen Issues Rebuttal to MedCap Letter 7VaxGen Issues Rebuttal to MedCap Letter 8VaxGen Issues Rebuttal to MedCap Letter 9VaxGen Issues Rebuttal to MedCap Letter 10VaxGen Issues Rebuttal to MedCap Letter 11
(Date:11/30/2009)... inaugural Global Conference on Systems & Enterpri...ington, DC, focuses on the convergence of complex ...portance to society. , The goal of the confe... around targeted complex systems, examined by doma...des Critical Infrastructure Systems, including Int...
(Date:11/30/2009)...the stress of seeing your extended family over the...search report in the December 2009 print issue of ...eukbio.org ) shows that you might be right. Here,s...lead to entirely new treatments that help keep aut... under control. That,s because researchers from th...
(Date:11/26/2009)...ressive antlers, red deer have been caught in the ...ers are much more than decorative. They are lethal...John Currey, from The University of York, UK, has ...e for over half a century and has become fascinate... long-standing collaboration with Tomas Landete-Ca...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 1Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 2Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 33SBio Inc to Report 2009 Third Quarter Earnings on November 12 2009 14616 13SBio Inc to Report 2009 Third Quarter Earnings on November 12 2009 14616 2Adding tools against breast tumors 60167 1
... Premature babies are subject to a host of threats...tudy published in the January 2008 issue of the Am...hers from the University of AlabamaBirmingham Medi...dicine found that genital mycoplasmas are a freque...nates born between 23 and 32 weeks of gestation ha...
... Recent inquiry into variation and evolution of re...d exciting and ground-breaking work within the pla...nal Journal of Plant Sciences, leading botanist Sp... together in a single volume some of the most comp...most growth: flowers and pollination, mating patte...
... CAMBRIDGE, Mass.--MIT researchers have uncovered ...ect birds and humans, a discovery that could help ...ins and aid in the development of vaccines against...hat a virus,s ability to infect humans depends on ...tor on the surface of human respiratory cells. , ...
Other Biology News:Bacterial infections in premature babies more common than previously realized 2A special issue of the International Journal of Plant Sciences 2A special issue of the International Journal of Plant Sciences 3MIT finds key to avian flu in humans 2MIT finds key to avian flu in humans 3
...staining method for labeling DNA breaks to detect ...s all the key reagents required for measuring apop...ntrol cells for assessing reagent performance; was...individual steps in the assay; terminal deoxynucle...
...lor staining method for labeling DNA breaks and to... cytometry. The kit contains the instructions and ... including: positive and negative control cells fo... and rinsing buffers for processing individual ste...
PROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad
Stirbar, Trans-Blot Plus cell from Bio-Rad
Biology Products: